|
| Age groups |
| Chi-square test | ||||||
| (20 - 35) | (35 - 50) | (51 - 65) | >65 | Total | |||||
| No. (%) | No. (%) | No. (%) | No. (%) | No (%) | χ2 | P-value | Sig. | ||
| ER | Negative | 25 (33.8%) | 92 (26.7%) | 114 (33.6%) | 65 (26.6%) | 296 (29.5%) 706 (70.5%) | 5.717 | 0.126 | NS |
| Positive | 49 (66.2%) | 253 (73.3%) | 225 (66.4%) | 179 (73.4%) | |||||
| Total | 74 (7.4%) | 345 (34.4%) | 339 (33.8) | 244 (24.4%) | 1002 (100%) | ||||
| PR | Negative | 31 (41.9%) | 101 (29.3%) | 122 (36.0%) | 81 (33.2%) | 335 (33.4) 667 (66.6) | 6.059 | 0.109 | NS |
| Positive | 43 (58.1%) | 244 (70.7%) | 217 (64.0%) | 163 (66.8%) | |||||
| Total | 74 (7.4%) | 345 (34.4% | 339 (33.8%) | 244 (24.4%) | 1002 (100%) | ||||
| HER2 | Negative | 41 (55.4%) | 249 (72.2%) | 243 (71.7%) | 183 (75.0%) | 716 (71.5%) 286 (28.5%) | 10.945 | 0.012 | S |
| Positive | 33 (44.6%) | 96 (27.8%) | 96 (28.3%) | 61 (25.0%) | |||||
| Total | 74 (7.4%) | 345 (34.4%) | 339 (33.8%) | 244 (24.4%) | 1002 (100%) | ||||